Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-17 Purchase | 2021-09-21 6:39 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC 10% Owner | 1,542,553 | $9.4 | $14,499,998 | 4,708,288 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-18 Equity Swap | 2024-05-20 8:08 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Director 10% Owner | 8,317,924 | $0 | 0 (Indirect) | View |
| 2024-05-20 Disposition | 2024-05-20 8:08 pm | N/A 2029-01-17 | ALPINE IMMUNE SCIENCES INC. | ALPN | Cui Xiangmin Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Director 10% Owner | 60,450 | $0 | 0 (Direct) | View |
| 2024-01-18 Exercise | 2024-01-22 6:54 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC 10% Owner | 1,234,636 | $12.74 | 6,582,380 (Direct) | View |
| 2024-01-18 Exercise | 2024-01-22 6:54 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC 10% Owner | 1,234,636 | $0 | 6,582,380 (Direct) | View |
| 2022-09-23 Option Award | 2022-09-27 4:46 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC 10% Owner | 2,000,000 | $7.35 | 6,708,288 (Direct) | View |
| 2021-09-28 Conversion | 2021-09-30 5:48 pm | N/A N/A | Cue Health Inc. | HLTH | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC 10% Owner | 8,192,468 | $0 | 8,192,468 (Direct) | View |
Ownership | 2021-09-23 9:06 pm | N/A N/A | Cue Health Inc. | HLTH | Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 8,192,468 (Direct) | View |